Delivery of macrophage-augmenting factors encapsulated in liposomes for destruction of tumor metastases.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000818:Animals; D007167:Immunotherapy; D008081:Liposomes / Q000008:administration & dosage*; D008175:Lung Neoplasms / Q000556:secondary* / Q000628:therapy; D008207:Lymphatic Metastasis; D008262:Macrophage Activation / Q000187:drug effects*; D008264:Macrophages / Q000502:physiology*; D008545:Melanoma / Q000628:therapy*; D051379:Mice; D009369:Neoplasms / Q000276:immunology; D009374:Neoplasms, Experimental / Q000628:therapy; D010714:Phosphatidylethanolamines / Q000008:administration & dosage / Q000627:therapeutic use*
D008081:Liposomes; D010714:Phosphatidylethanolamines; C037144:mifamurtide; D000119:Acetylmuramyl-Alanyl-Isoglutamine